Growing community of inventors

Tampere, Finland

Kari Lehmussaari

Average Co-Inventor Count = 3.91

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 52

Kari LehmussaariOlli Oksala (5 patents)Kari LehmussaariTimo Reunamaki (5 patents)Kari LehmussaariEsko Pohjala (2 patents)Kari LehmussaariPertti Pellinen (2 patents)Kari LehmussaariEija Vartiainen (2 patents)Kari LehmussaariSakari Alaranta (2 patents)Kari LehmussaariJarkko Ruohonen (1 patent)Kari LehmussaariHeikki Nupponen (1 patent)Kari LehmussaariMarkku Peralampi (1 patent)Kari LehmussaariKari Lehmussaari (6 patents)Olli OksalaOlli Oksala (5 patents)Timo ReunamakiTimo Reunamaki (5 patents)Esko PohjalaEsko Pohjala (7 patents)Pertti PellinenPertti Pellinen (2 patents)Eija VartiainenEija Vartiainen (2 patents)Sakari AlarantaSakari Alaranta (2 patents)Jarkko RuohonenJarkko Ruohonen (2 patents)Heikki NupponenHeikki Nupponen (3 patents)Markku PeralampiMarkku Peralampi (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Santen Oy (3 from 4 patents)

2. Asahi Glass Company, Limited (1 from 2,560 patents)

3. Agc Inc. (1 from 1,027 patents)

4. Santen Pharmaceutical Co., Ltd. (1 from 282 patents)

5. Leiras Oy (1 from 40 patents)

6. Santen Pharmaceuticalco., Ltd. (1 from 2 patents)


6 patents:

1. 10864159 - Method and composition for treating ocular hypertension and glaucoma

2. 9999593 - Method and composition for treating ocular hypertension and glaucoma

3. 5795913 - Ophthalmic composition

4. 5776499 - Process for preparing a clodronate preparation

5. 5767143 - Ophthalmological preparation

6. 5710182 - Ophthalmic composition

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…